News - Quintiles

By: Innovex  11-11-2011
Keywords: press release, Commercial Services, Product Distribution

Press Release — October 28, 2011 – Quintiles is ranked 25th in the inaugural World’s Best Multinational Workplaces list from the Great Place to Work® Institute.

Press Release — October 26, 2011 – To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles signed of a definitive agreement to acquire Advion BioServices.

Quintiles Highlights

Hear from the Experts — Michael Ackermann, Ph.D., Vice President of Global Commercial Strategy and Alliance, Global Commercial Solutions at Quintiles, discusses the factors that are leading to a radical shift in how biopharmaceutical products are developed and commercialized.

White Paper — As healthcare decision making becomes more complex, stakeholders are demanding real-world evidence tailored to their own individual needs.

Watch Video

In your world, every grain of data matters — and every minute counts. To make the most of what you’ve got, turn to Model-Based Drug Development.

Press Release — October 19, 2011 – Quintiles announced the acquisition of VCG & Associates and VCG BIO. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

Keywords: Commercial Services, press release, Product Distribution

Other products and services from Innovex


Quintiles Acquires VCG & Associates and VCG Bio

We have worked closely with Quintiles for the past several years, and this acquisition is a natural step that allows both organizations to serve our customers with specialized commercialization offerings. VCG develops strategic healthcare marketing initiatives to address the challenges surrounding U.S. pharmaceutical market entry. Our team is very excited to join Quintiles,” VCG Co-Founder and Managing Partner Brad Fleahman said.